FdaApplication
NDA 020885
Identifiers
- fda_app_no: NDA020885
Properties
| Property | Value |
|---|---|
| applicant_name | APOTEX INC |
| application_type | NDA |
| approval_date | 1998-10-09 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PAXIL | PAROXETINE HYDROCHLORIDE | EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| PAXIL | PAROXETINE HYDROCHLORIDE | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| PAXIL | PAROXETINE HYDROCHLORIDE | EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| PAXIL | PAROXETINE HYDROCHLORIDE | EQ 30MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
4 products